Statistical Approaches for Hepatocellular Carcinoma (HCC) Biomarker Discovery

Bio informat ics provides an essential tool for the identification of diseases especially human cancer diseases. Also, the availab ility of the co mplete hu man genome has opened the door for the understanding of these diseases as recent technological advances in functional genomics and proteomics have fuelled interest in identifying the biomarkers of complex diseases such as liver cancer which main ly caused to death. Hepatocellular carcinoma (HCC) is one of the co mmon malignant tumours in the world; the liver cirrhosis is the most important leading cause of it. HCC relates to virus infection, carcinogenic compounds, pollution and genetic factors. This work provides a genomic study that focuses on using bioinformat ics approaches to predict the molecular causes of HCC by the investigation of the chromosomal aberrations including gain, or loss of the genomic DNA copy number to provide accurate diagnoses of this disease using Comparative genomic hybridizat ion (CGH) arrays. Diagnosis and understanding of the disease processes will provide a potential t reat ment of the disease at an early stage. The aim is to apply two statistical approaches based on a circular binary segmentation (CBS) algorith m and a Bayesian Hidden Markov Model (HMM ) to a number of hu man chromosomes for analysing array CGH data that accounts for the dependence between neighbouring clones in order to identify genome-wide alternations in copy number fro m the genomic data. Results provide a well identification of the aberration regions in hu man chro mosomes that may lead to robust biomarkers for the early detection of human HCC.

[1]  V. Mazzaferro,et al.  Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. , 2008, Mutation research.

[2]  Gilles Celeux,et al.  A statistical approach for CGH microarray data analysis , 2004 .

[3]  Kevin P. Murphy,et al.  Integrating copy number polymorphisms into array CGH analysis using a robust HMM , 2006, ISMB.

[4]  Takehide Asano,et al.  Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.

[5]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[6]  Y. Chung,et al.  An Overview of Biomarkers and Molecular Signatures in HCC , 2010, Cancers.

[7]  X. Guan,et al.  Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma , 2002, Cancer.

[8]  N. Nishida,et al.  Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis , 2005, Genes, chromosomes & cancer.

[9]  M. S. Mabrouk,et al.  K6. Circular binary segmentation modeling of array CGH data on hepatocellular carcinoma , 2012, 2012 29th National Radio Science Conference (NRSC).

[10]  Jaakko Astola,et al.  CGH-Plotter: MATLAB toolbox for CGH-data analysis , 2003, Bioinform..

[11]  R. Scharpf,et al.  A multilevel model to address batch effects in copy number estimation using SNP arrays. , 2011, Biostatistics.

[12]  Yunyu Zhang,et al.  Hidden Markov Model inference copy number change in array-CGH data , 2005 .

[13]  Xiaolin Yin,et al.  Detecting Copy Number Variations from Array CGH Data Based on a Conditional Random Field Model , 2010, J. Bioinform. Comput. Biol..

[14]  Johan Staaf,et al.  Continuous-index hidden Markov modelling of array CGH copy number data , 2007, Bioinform..

[15]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[16]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[17]  R. Eils,et al.  Etiology‐dependent molecular mechanisms in human hepatocarcinogenesis , 2007, Hepatology.

[18]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[19]  Yi Li,et al.  Bayesian Hidden Markov Modeling of Array CGH Data , 2008, Journal of the American Statistical Association.

[20]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[21]  E. S. Venkatraman,et al.  A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..

[22]  J M Trent,et al.  Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization , 2000, Genes, chromosomes & cancer.

[23]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[24]  Yuedong Wang,et al.  Statistical methods for detecting genomic alterations through array-based comparative genomic hybridization (CGH). , 2004, Frontiers in bioscience : a journal and virtual library.

[25]  Bauke Ylstra,et al.  Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization , 2003, The Journal of pathology.

[26]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[27]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[28]  N. Nishida,et al.  Comprehensive allelotyping of well‐differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss , 2002, Genes, chromosomes & cancer.

[29]  S. L. Scott Bayesian Methods for Hidden Markov Models , 2002 .

[30]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[31]  H. Döhner,et al.  Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.